| Liver Lymphoma studied in …STUDIED_INderived70 of 70show fewer |
|---|
| → studied in | NCT04115631Phase 2 · active not recruiting A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Liver Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055477Phase 1 · recruiting A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · condition mapped CURATED_BROADER · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05475925Phase 1/Phase 2 · recruiting A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02232516Phase 2 · completed Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598998Phase 1/Phase 2 · active not recruiting Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas · condition mapped CURATED_BROADER · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804166Phase 4 · completed A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168140Phase 1 · completed CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769222Phase 1 · terminated Ipilimumab and Local Radiation for Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02561273Phase 1/Phase 2 · completed Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04795869Phase 2 · withdrawn Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma · condition mapped CURATED_BROADER · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01336933Phase 2 · completed Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04639843Phase 1 · withdrawn Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261247Phase 2 · completed Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01805037Phase 1/Phase 2 · terminated Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678443Phase 1 · terminated Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258998Phase 2 · completed Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01075321Phase 1/Phase 2 · completed Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03075553Phase 2 · terminated Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918333Phase 1/Phase 2 · completed Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02533700Phase 2 · unknown CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003196NA · completed Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326702Phase 1/Phase 2 · completed Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02087878withdrawn A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839916Phase 2 · completed Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408043NA · terminated Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01590732Phase 1 · completed Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma · condition mapped CURATED_BROADER · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129193Phase 1 · completed AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567709Phase 1 · completed Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01719835Phase 2 · unknown CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study · condition mapped ALIAS · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746992Phase 4 · unknown CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01419795Phase 2 · terminated Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072514Phase 2 · completed Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427881Phase 2 · completed Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049504Phase 2 · completed Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742727Phase 1/Phase 2 · unknown CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652014Phase 2 · withdrawn Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01466881Phase 2 · completed Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01748721Phase 1 · completed MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131937Phase 2 · completed Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658319Phase 1 · completed Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01959477early Phase 1 · completed Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608361Phase 1 · completed Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769911NA · withdrawn Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00901147Phase 2 · completed Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00933985Phase 1 · terminated Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101205Phase 1 · terminated Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458731Phase 1 · completed Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129180Phase 1 · completed Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00731536completed Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116154Phase 1 · terminated Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01177371Phase 2 · completed High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (8 active) | — | — | Hepatosplenic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |